Helping patients reclaim a life of possibility
From 6-9 December Myeloma Patients Europe (MPE) attended the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida. Over 20,000 researchers, doctors, nurses and patient advocates attended the meeting to share and discuss the results of the latest research from across blood cancers. ASH was a great way to close out another successful year…
Myeloma Patients Europe (MPE) will host a webinar covering key updates on myeloma presented at the American Society of Hematology (ASH) Annual Congress, which will take place from 6–9 December 2025 in Orlando, Florida, USA. The webinar will be held on Wednesday, 17 December 2025, from 17:00 – 18:00 CET. It will be led by Prof. Dr. Hermann Einsele, Director of the Department…
On Saturday, 18 October, a regional meeting of patients, doctors, associations, and institutional representatives from Bosnia and Herzegovina, Croatia, and Serbia was held in Sarajevo, under the title “Together for Life with Myeloma” – Myeloma Day 2025, organised by Mijelom u BiH, (the Association of Patients with Multiple Myeloma, Myelodysplastic Syndrome, and Other Rare Blood Diseases…
This September, our Slovenian member organisation, Društvo BKB, once again marked Blood Cancer Awareness Month and European Myeloma Day, with a wide range of activities dedicated to raising awareness and supporting patients across Slovenia. They organised 12 information stands in health centres, hospitals, and at the University Medical Centres in Ljubljana and Maribor. A special…
Throughout September, the Multiple Myeloma Patient Association of Serbia (MMPAS) marked Blood Cancer Awareness Month with a powerful and heartfelt series of activities across the country — especially in smaller towns, where awareness of multiple myeloma remains extremely low. Guided by empathy and driven by purpose, they launched two national campaigns focused on informing, educating,…
On September 17-20, Myeloma Patients Europe (MPE) attended the International Myeloma Society (IMS) Annual Meeting in Toronto, Canada. It is one of the most important conferences for world-renowned myeloma experts and researchers. The IMS Annual Meeting focuses on basic science, preclinical, and clinical aspects. MPE was there to learn about the latest clinical updates…
How are costs and medicine effectiveness part of decision-making in medicine access? Thursday, 9 October 2025, 17:00 – 18:30 CET Aimed at patients, carers and patient advocates, as well as to a general audience, the webinar will provide basic knowledge on the topic of cost-effectiveness analysis in decision-making (including health technology assessment) on new medicines.…
We held our latest webinar on September 11th, called Myeloma and infection: clinical and lived perspectives for myeloma patients, carers and advocates. Jackie Quinn, Myeloma Clinical Nurse Specialist, Belfast Trust presented on how myeloma and treatments increase infection risk, covering immunisations, bispecific antibody risks, and preventive medications. Mimi Quinn, myeloma patient from Ireland shared her personal…